InsiderPulseNo transactions found.
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Formation and operating costs | $1.1M+435.8% | $202K+4639.2% | $4K |
| Loss from operations | -$1.1M-435.8% | -$202K-4639.2% | -$4K |
| Interest and dividend income on investments held in Trust | $2.9M+738.7% | $345K | $0 |
| Net income | $1.8M+1166.1% | $143K+3457.9% | -$4K |
| Weighted average shares outstanding of redeemable ordinary shares | $6.9M+756.6% | $805K | $0 |
| Basic and diluted net income per share, ordinary shares | $0.32-88.0% | $2.67 | $0 |
| Weighted average shares outstanding of non-redeemable ordinary shares | $2.2M+22.7% | $1.8M+3.0% | $1.7M |
| Basic and diluted net loss per share, non-redeemable ordinary shares | -$0.2+82.3% | -$1.13 | $0 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Horizon Space Acquisition II Corp. Clarifies Redemption Process for Business Combination Shareholder Meeting and Extension Shareholder Meeting
Horizon Space Acquisition II postpones extraordinary general meeting
Horizon Space Acquisition II Corp. Postponed the Extraordinary General Meeting to February 12, 2026 and Extended the Redemption Request Deadline
SL BIO Ltd. and Horizon Space Acquisition II Corp. Announce Registration Statement Effectiveness and Extraordinary General Meeting Date to Approve Business Combination